4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-20-011263
Chief R&D Officer sold 4,774 shares at $22.35 ($106,699)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Zalevsky Jonathan Chief R&D Officer | 2020-02-18 | Sale | −4,774 | $22.35 | $106,699 | 327,073 | D |
| Open-market sales · 4,774 sh · avg $22.35 · $106,699 | |||||||
Loading xslF345X03/doc4.xml…